CLB Quote, Financials, Valuation and Earnings

Halliburton Co. has a net margin of 5.25% compared to Core Laboratories Inc.'s net margin of 10.41%. Core Laboratories Inc.'s return on equity of 12.12% beat Halliburton Co.'s return on equity of 12.36%.

Core Laboratories Inc. has a consensus price target of $15.83, signalling downside risk potential of -14.69%. On the other hand Halliburton Co. has an analysts' consensus of $36.02 which suggests that it could grow by 6.06%. Given that Halliburton Co. has higher upside potential than Core Laboratories Inc., analysts believe Halliburton Co. is more attractive than Core Laboratories Inc..

Core Laboratories Inc. has a beta of 1.092, which suggesting that the stock is 9.225% more volatile than S&P 500. In comparison Halliburton Co. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.896%.

Core Laboratories Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0.22%. Halliburton Co. offers a yield of 2% to investors and pays a quarterly dividend of $0.17 per share. Core Laboratories Inc. pays 5.88% of its earnings as a dividend. Halliburton Co. pays out 45.21% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories Inc. quarterly revenues are $138.3M, which are smaller than Halliburton Co. quarterly revenues of $5.7B. Core Laboratories Inc.'s net income of $7.3M is lower than Halliburton Co.'s net income of $589M. Notably, Core Laboratories Inc.'s price-to-earnings ratio is 27.55x while Halliburton Co.'s PE ratio is 22.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories Inc. is 1.66x versus 1.31x for Halliburton Co.. Usually stocks with elevated PS ratios are considered overvalued.

Oceaneering International, Inc. has a net margin of 5.25% compared to Core Laboratories Inc.'s net margin of 9.6%. Core Laboratories Inc.'s return on equity of 12.12% beat Oceaneering International, Inc.'s return on equity of 29.28%.

Core Laboratories Inc. has a consensus price target of $15.83, signalling downside risk potential of -14.69%. On the other hand Oceaneering International, Inc. has an analysts' consensus of $24.50 which suggests that it could fall by -26.09%. Given that Oceaneering International, Inc. has more downside risk than Core Laboratories Inc., analysts believe Core Laboratories Inc. is more attractive than Oceaneering International, Inc..

Core Laboratories Inc. has a beta of 1.092, which suggesting that the stock is 9.225% more volatile than S&P 500. In comparison Oceaneering International, Inc. has a beta of 1.256, suggesting its more volatile than the S&P 500 by 25.631%.

Core Laboratories Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0.22%. Oceaneering International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Core Laboratories Inc. pays 5.88% of its earnings as a dividend. Oceaneering International, Inc. pays out -- of its earnings as a dividend. Core Laboratories Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories Inc. quarterly revenues are $138.3M, which are smaller than Oceaneering International, Inc. quarterly revenues of $742.9M. Core Laboratories Inc.'s net income of $7.3M is lower than Oceaneering International, Inc.'s net income of $71.3M. Notably, Core Laboratories Inc.'s price-to-earnings ratio is 27.55x while Oceaneering International, Inc.'s PE ratio is 14.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories Inc. is 1.66x versus 1.19x for Oceaneering International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

RPC, Inc. has a net margin of 5.25% compared to Core Laboratories Inc.'s net margin of -0.72%. Core Laboratories Inc.'s return on equity of 12.12% beat RPC, Inc.'s return on equity of 2.88%.

Core Laboratories Inc. has a consensus price target of $15.83, signalling downside risk potential of -14.69%. On the other hand RPC, Inc. has an analysts' consensus of $6.20 which suggests that it could grow by 6.53%. Given that RPC, Inc. has higher upside potential than Core Laboratories Inc., analysts believe RPC, Inc. is more attractive than Core Laboratories Inc..

Core Laboratories Inc. has a beta of 1.092, which suggesting that the stock is 9.225% more volatile than S&P 500. In comparison RPC, Inc. has a beta of 0.720, suggesting its less volatile than the S&P 500 by 28.008%.

Core Laboratories Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0.22%. RPC, Inc. offers a yield of 2.75% to investors and pays a quarterly dividend of $0.04 per share. Core Laboratories Inc. pays 5.88% of its earnings as a dividend. RPC, Inc. pays out 109.44% of its earnings as a dividend. Core Laboratories Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but RPC, Inc.'s is not.

Core Laboratories Inc. quarterly revenues are $138.3M, which are smaller than RPC, Inc. quarterly revenues of $425.8M. Core Laboratories Inc.'s net income of $7.3M is higher than RPC, Inc.'s net income of -$3.1M. Notably, Core Laboratories Inc.'s price-to-earnings ratio is 27.55x while RPC, Inc.'s PE ratio is 39.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories Inc. is 1.66x versus 0.76x for RPC, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

SLB Ltd. has a net margin of 5.25% compared to Core Laboratories Inc.'s net margin of 8.22%. Core Laboratories Inc.'s return on equity of 12.12% beat SLB Ltd.'s return on equity of 14.52%.

Core Laboratories Inc. has a consensus price target of $15.83, signalling downside risk potential of -14.69%. On the other hand SLB Ltd. has an analysts' consensus of $54.58 which suggests that it could grow by 8.32%. Given that SLB Ltd. has higher upside potential than Core Laboratories Inc., analysts believe SLB Ltd. is more attractive than Core Laboratories Inc..

Core Laboratories Inc. has a beta of 1.092, which suggesting that the stock is 9.225% more volatile than S&P 500. In comparison SLB Ltd. has a beta of 0.726, suggesting its less volatile than the S&P 500 by 27.443%.

Core Laboratories Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0.22%. SLB Ltd. offers a yield of 2.28% to investors and pays a quarterly dividend of $0.30 per share. Core Laboratories Inc. pays 5.88% of its earnings as a dividend. SLB Ltd. pays out 48.55% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories Inc. quarterly revenues are $138.3M, which are smaller than SLB Ltd. quarterly revenues of $9.7B. Core Laboratories Inc.'s net income of $7.3M is lower than SLB Ltd.'s net income of $800M. Notably, Core Laboratories Inc.'s price-to-earnings ratio is 27.55x while SLB Ltd.'s PE ratio is 21.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories Inc. is 1.66x versus 2.03x for SLB Ltd.. Usually stocks with elevated PS ratios are considered overvalued.